The asset-centric business model: the established trend in venture capital investing

Advances in genomics and proteomics, completion of the human genome, creation of bio banks, new scientific insights and development of targeted diagnostics and therapeutics have created tremendous opportunities for new companies to emerge. Nurturing these start-up takes great care and the right sustenance. The challenge for the founders are always ever-changing, some of the biggest hurdles beings setting-up up the company and acquiring the financing required to take a promising innovation all the way to the finish line.The Jumpstarting Innovation Forum will be an engaging two-day session on the role of early stage investing, innovative models of funding and incubation, with a range of international speakers, from biotech companies and incubators to some of the top tier venture funds in this area as well as some of the leading pharma companies